CA116804/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2008	3
2009	5
2010	3
2011	3
2012	9
2013	1
2014	3
2015	1
2016	1
2017	3
2018	1
2019	1
2021	1
2024	0

1

Targeting HIF-activated collagen prolyl 4-hydroxylase expression disrupts collagen deposition and blocks primary and metastatic uveal melanoma growth.

Kaluz S, Zhang Q, Kuranaga Y, Yang H, Osuka S, Bhattacharya D, Devi NS, Mun J, Wang W, Zhang R, Goodman MM, Grossniklaus HE, Van Meir EG. Kaluz S, et al. Oncogene. 2021 Aug;40(33):5182-5191. doi: 10.1038/s41388-021-01919-x. Epub 2021 Jul 3. Oncogene. 2021. PMID: 34218269 Free PMC article.

2

Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma.

Dong L, You S, Zhang Q, Osuka S, Devi NS, Kaluz S, Ferguson JH, Yang H, Chen G, Wang B, Grossniklaus HE, Van Meir EG. Dong L, et al. Clin Cancer Res. 2019 Apr 1;25(7):2206-2218. doi: 10.1158/1078-0432.CCR-18-1368. Epub 2018 Dec 18. Clin Cancer Res. 2019. PMID: 30563937 Free PMC article.

3

A novel small-molecule arylsulfonamide causes energetic stress and suppresses breast and lung tumor growth and metastasis.

Dai X, Kaluz S, Jiang Y, Shi L, Mckinley D, Wang Y, Wang B, Van Meir EG, Tan C. Dai X, et al. Oncotarget. 2017 Oct 29;8(59):99245-99260. doi: 10.18632/oncotarget.22104. eCollection 2017 Nov 21. Oncotarget. 2017. PMID: 29245898 Free PMC article.

4

Purifying Properly Folded Cysteine-rich, Zinc Finger Containing Recombinant Proteins for Structural Drug Targeting Studies: the CH1 Domain of p300 as a Case Example.

Kim YJ, Kaluz S, Mehta A, Weinert E, Rivera S, Van Meir EG. Kim YJ, et al. Bio Protoc. 2017 Sep 5;7(17):e2537. doi: 10.21769/BioProtoc.2537. Bio Protoc. 2017. PMID: 28966947 Free PMC article.

5

Examining the structure-activity relationship of benzopyran-based inhibitors of the hypoxia inducible factor-1 pathway.

Ferguson J, De Los Santos Z, Devi N, Van Meir E, Zingales S, Wang B. Ferguson J, et al. Bioorg Med Chem Lett. 2017 Apr 15;27(8):1731-1736. doi: 10.1016/j.bmcl.2017.02.073. Epub 2017 Mar 1. Bioorg Med Chem Lett. 2017. PMID: 28285917 Free PMC article.

6

Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase.

Kalinina J, Ahn J, Devi NS, Wang L, Li Y, Olson JJ, Glantz M, Smith T, Kim EL, Giese A, Jensen RL, Chen CC, Carter BS, Mao H, He M, Van Meir EG. Kalinina J, et al. Clin Cancer Res. 2016 Dec 15;22(24):6256-6265. doi: 10.1158/1078-0432.CCR-15-2965. Epub 2016 Jun 23. Clin Cancer Res. 2016. PMID: 27340277 Free PMC article.

7

Biology of advanced uveal melanoma and next steps for clinical therapeutics.

Luke JJ, Triozzi PL, McKenna KC, Van Meir EG, Gershenwald JE, Bastian BC, Gutkind JS, Bowcock AM, Streicher HZ, Patel PM, Sato T, Sossman JA, Sznol M, Welch J, Thurin M, Selig S, Flaherty KT, Carvajal RD. Luke JJ, et al. Pigment Cell Melanoma Res. 2015 Mar;28(2):135-47. doi: 10.1111/pcmr.12304. Epub 2014 Sep 1. Pigment Cell Melanoma Res. 2015. PMID: 25113308 Free PMC article. Review.

8

Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex.

Fan J, Shan C, Kang HB, Elf S, Xie J, Tucker M, Gu TL, Aguiar M, Lonning S, Chen H, Mohammadi M, Britton LM, Garcia BA, Alečković M, Kang Y, Kaluz S, Devi N, Van Meir EG, Hitosugi T, Seo JH, Lonial S, Gaddh M, Arellano M, Khoury HJ, Khuri FR, Boggon TJ, Kang S, Chen J. Fan J, et al. Mol Cell. 2014 Feb 20;53(4):534-48. doi: 10.1016/j.molcel.2013.12.026. Epub 2014 Jan 30. Mol Cell. 2014. PMID: 24486017 Free PMC article.

9

P14ARF suppresses tumor-induced thrombosis by regulating the tissue factor pathway.

Zerrouqi A, Pyrzynska B, Brat DJ, Van Meir EG. Zerrouqi A, et al. Cancer Res. 2014 Mar 1;74(5):1371-8. doi: 10.1158/0008-5472.CAN-13-1951. Epub 2014 Jan 7. Cancer Res. 2014. PMID: 24398474 Free PMC article.

10

Hypoxia inducible factor pathway inhibitors as anticancer therapeutics.

Burroughs SK, Kaluz S, Wang D, Wang K, Van Meir EG, Wang B. Burroughs SK, et al. Future Med Chem. 2013 Apr;5(5):553-72. doi: 10.4155/fmc.13.17. Future Med Chem. 2013. PMID: 23573973 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year